Mark Leschly, 10% Owner at ADVANCIS PHARMACEUTICAL CORP (AVNC), bought 1,200,000 shares at $2.36 ($2.8M) on 2007-04-12, disclosed to the SEC on 2007-04-16.
Open-market purchase of $2.8M AVNC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| CARA | BUY | 2014-02-05 | $2.5M | — | Filing → |
| BFLY | BUY | 2012-11-15 | $299K | — | Filing → |
| ANAC | BUY | 2010-12-01 | $12.0M | — | Filing → |